Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Roger, Laitt"'
Autor:
Daniel Moualed, Jonathan Wong, Owen Thomas, Calvin Heal, Rukhtam Saqib, Cameron Choi, Simon Lloyd, Scott Rutherford, Emma Stapleton, Charlotte Hammerbeck-Ward, Omar Pathmanaban, Roger Laitt, Miriam Smith, Andrew Wallace, Mark Kellett, Gareth Evans, Andrew King, Simon Freeman
Publikováno v:
Moualed, D, Wong, J, Thomas, O, Heal, C, Saqib, R, Choi, C, Lloyd, S, Rutherford, S A, Stapleton, E, Hammerbeck-ward, C, Pathmanaban, O, Laitt, R, Smith, M, Wallace, A, Kellett, M, Evans, G, King, A & Freeman, S 2022, ' Prevalence and natural history of schwannomas in Neurofibromatosis type 2 (NF2): the influence of pathogenic variants ', European Journal of Human Genetics, vol. 30, no. 4, pp. 458-464 . https://doi.org/10.1038/s41431-021-01029-y
Eur J Hum Genet
Eur J Hum Genet
Aims: To characterise the natural history of vestibular, trigeminal and lower cranial nerve schwannomas (VS, TS, LCNS) in patients with Neurofibromatosis type 2 (NF2). To understand how pathogenic variants (PVs) of the NF2 gene affect tumour burden a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e78568512549322abcc754a61c58af03
https://doi.org/10.1038/s41431-021-01029-y
https://doi.org/10.1038/s41431-021-01029-y
Autor:
Omar N. Pathmanaban, Miriam J. Smith, Simon R. Freeman, Raji Anup, Mary Perry, D. Gareth Evans, Elaine F. Harkness, Emma Stapleton, Roger Laitt, Simon Tobi, Allyson Parry, Rupert Obholzer, Andrew T. King, Naomi L. Bowers, Philip T Smith, Shazia K. Afridi, Mark Kellett, Owen M. Thomas, Chris Duff, Grace Vassallo, Juliette Gair, Andrew J Wallace, Simon K W Lloyd, Scott A. Rutherford, Claire Hartley, Charlotte Hammerbeck-Ward, Stavros Stivaros, Patrick R. Axon, Dorothy Halliday
Publikováno v:
English Specialist NF research group 2019, ' Incidence of mosaicism in 1055 de novo NF2 cases: Much higher than previous estimates with high utility of Next Generation Sequencing. ', Genetics in Medicine . https://doi.org/10.1038/s41436-019-0598-7
PURPOSE: To evaluate the incidence of mosaicism in de novo neurofibromatosis 2 (NF2).METHODS: Patients fulfilling NF2 criteria, but with no known affected family member from a previous generation (n = 1055), were tested for NF2 variants in lymphocyte
Autor:
Omar N. Pathmanaban, Mary Perry, Patrick R. Axon, Dorothy Halliday, Miriam J. Smith, Owen M. Thomas, Roger Laitt, Allyson Parry, Juliette Gair, Mark Kellett, Elaine F. Harkness, Emma Stapleton, Rosalie E. Ferner, Simon R. Freeman, Andrew J Wallace, Simon K.L. Lloyd, Scott A. Rutherford, Naomi L. Bowers, Andrew T. King, Shazia K. Afridi, Raji Anup, Simon Tobi, D. Gareth Evans, Charlotte Hammerbeck-Ward
Publikováno v:
The English Specialist NF2 research group 2019, ' Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testing ', Genetics in Medicine, vol. 21, no. 7, pp. 1525-1533 . https://doi.org/10.1038/s41436-018-0384-y
Purpose: We have evaluated deficiencies in existing diagnostic criteria for neurofibromatosis 2 (NF2). Methods: Two large databases of individuals fulfilling NF2 criteria (n=1361) and those tested for NF2 variants with criteria short of diagnosis (n=
Autor:
Andrew T. King, Elaine F. Harkness, Emma M. Stapleton, D. Gareth Evans, Scott A. Rutherford, Grace Vassallo, Stavros Stivaros, Roger Laitt, Omar N. Pathmanaban, Claire Forde, Simon Kerrigan, Simon R. Freeman, Martin G. McCabe, Miriam J. Smith, Charlotte Hammerbeck-Ward, Simon K W Lloyd, John Paul Kilday, Catherine McBain, Owen M. Thomas
Publikováno v:
Neuro Oncol
Background Limited data exist on the disease course of neurofibromatosis type 2 (NF2) to guide clinical trial design. Methods A prospective database of patients meeting NF2 diagnostic criteria, reviewed between 1990 and 2020, was evaluated. Follow-up
Autor:
Mark Kellett, Omar N. Pathmanaban, Andrew T. King, Charlotte Hammerbeck-Ward, Jemma Bischetsrieder, Patrick R. Axon, Scott A. Rutherford, Miriam J. Smith, Simon R. Freeman, Jaishri O. Blakeley, D. Gareth Evans, Owen M. Thomas, Claire Hartley, Roger Laitt, Andrew J Wallace, Simon K W Lloyd
Publikováno v:
The Laryngoscope
Evans, D G, Wallace, A J, Hartley, C, Freeman, S R, Lloyd, S K, Owen, T, Axon, P R, Hammerbeck-Ward, C, Pathmanaban, O, Rutherford, S A, Kellett, M, Laitt, R, King, A, Bischetsrieder, J, Blakeley, J & Smith, M J 2018, ' Familial unilateral vestibular schwannoma is rarely caused by inherited variants in the NF2 gene ', The Laryngoscope, vol. 129, no. 4, pp. 967-973 . https://doi.org/10.1002/lary.27554
Evans, D G, Wallace, A J, Hartley, C, Freeman, S R, Lloyd, S K, Owen, T, Axon, P R, Hammerbeck-Ward, C, Pathmanaban, O, Rutherford, S A, Kellett, M, Laitt, R, King, A, Bischetsrieder, J, Blakeley, J & Smith, M J 2018, ' Familial unilateral vestibular schwannoma is rarely caused by inherited variants in the NF2 gene ', The Laryngoscope, vol. 129, no. 4, pp. 967-973 . https://doi.org/10.1002/lary.27554
Objectives/hypothesis Unilateral vestibular schwannoma (VS) occurs with a lifetime risk of around 1 in 1,000 and is due to inactivation of the NF2 gene, either somatically or from a constitutional mutation. It has been postulated that familial occurr
Autor:
Simon R. Freeman, Owen M. Thomas, Claire Hartley, Chris Duff, Roger Laitt, Omar N. Pathmanaban, Miriam J. Smith, Andrew J Wallace, D. Gareth Evans, Simon K W Lloyd, Rosalie E. Ferner, John Ealing, Naomi L. Bowers, Scott A. Rutherford, Amy Taylor, Charlotte Hammerbeck-Ward, Dorothy Halliday, Mark Kellett, Simon Tobi, Andrew T. King, Elaine F. Harkness
Publikováno v:
Evans, D G, Bowers, N L, Tobi, S, Hartley, C, Wallace, A J, King, A T, Lloyd, S K W, Rutherford, S A, Hammerbeck-Ward, C, Pathmanaban, O N, Freeman, S R, Ealing, J, Kellett, M, Laitt, R, Thomas, O, Halliday, D, Ferner, R, Taylor, A, Duff, C, Harkness, E F & Smith, M J 2018, ' Schwannomatosis: a genetic and epidemiological study ', Journal of Neurology, Neurosurgery and Psychiatry, vol. 89, no. 11, pp. 1215-1219 . https://doi.org/10.1136/jnnp-2018-318538
ObjectivesSchwannomatosis is a dominantly inherited condition predisposing to schwannomas of mainly spinal and peripheral nerves with some diagnostic overlap with neurofibromatosis-2 (NF2), but the underlying epidemiology is poorly understood. We pre
Autor:
D Gareth, Evans, Claire L, Hartley, Philip T, Smith, Andrew T, King, Naomi L, Bowers, Simon, Tobi, Andrew J, Wallace, Mary, Perry, Raji, Anup, Simon K W, Lloyd, Scott A, Rutherford, Charlotte, Hammerbeck-Ward, Omar N, Pathmanaban, Emma, Stapleton, Simon R, Freeman, Mark, Kellett, Dorothy, Halliday, Allyson, Parry, Juliette J, Gair, Patrick, Axon, Roger, Laitt, Owen, Thomas, Shazia K, Afridi, Rupert, Obholzer, Chris, Duff, Stavros M, Stivaros, Grace, Vassallo, Elaine F, Harkness, Miriam J, Smith
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics. 22(1)
To evaluate the incidence of mosaicism in de novo neurofibromatosis 2 (NF2).Patients fulfilling NF2 criteria, but with no known affected family member from a previous generation (n = 1055), were tested for NF2 variants in lymphocyte DNA and where ava
Autor:
Roger Laitt, Mark Kellett, Andrew T. King, Stavros Stivaros, Owen M. Thomas, Scott A. Rutherford, Freeman Sm, Chorlatte L. Hammerbeck-Ward, Omar N. Pathmanaban, Evans Dg, Rodriguez-Valero M, Simon K W Lloyd
Publikováno v:
King, A, SA, R, C, H-W, SK, L, SM, F, ON, P, M, R-V, OM, T, RD, L, S, S, M, K & DG, E 2018, ' High-Grade Glioma is not a Feature of Neurofibromatosis Type 2 in the Unirradiated Patient. ', Neurosurgery . https://doi.org/10.1093/neuros/nyx374
BackgroundThe Manchester criteria for Neurofibromatosis Type 2 (NF2) includes a range of tumours, and gliomas were incorporated in the original description. The gliomas are now widely accepted to be predominantly spinal cord ependymomas.ObjectWe have
Publikováno v:
Otorhinolaryngology: Head and Neck Surgery (2 Volumes)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28544fb8054d4ca4898f725da96bfa48
https://doi.org/10.5005/jp/books/13036_99
https://doi.org/10.5005/jp/books/13036_99
Autor:
Charlotte Hammerbeck-Ward, Simon K W Lloyd, Omar N. Pathmanaban, Allyson Parry, Mark Kellett, Roger Laitt, Rupert Obholzer, Shazia K. Afridi, Patrick R. Axon, Dorothy Halliday, D. Gareth Evans, Andrew T. King, Stavros Stivaros, Sara Erridge, Martin G. McCabe, Scott A. Rutherford, Owen M. Thomas, Simon R. Freeman
Publikováno v:
King, A T, Rutherford, S A, Hammerbeck-ward, C, Lloyd, S K, Freeman, S R, Pathmanaban, O, Kellett, M, Obholzer, R, Afridi, S, Axon, P, Halliday, D, Parry, A, Thomas, O M, Laitt, R D, Mccabe, M, Stivaros, S, Erridge, S C & Evans, D G 2018, ' Malignant Peripheral Nerve Sheath Tumors are not a Feature of Neurofibromatosis Type 2 in the Unirradiated Patient ', Neurosurgery, vol. 83, no. 1, pp. 38-42 . https://doi.org/10.1093/neuros/nyx368, https://doi.org/10.1093/neuros/nyx368
Background The published literature suggests that malignant peripheral nerve sheath tumors (MPNST) occur at increased frequency in neurofibromatosis type 2 (NF2). A recent review based on incidence data in North America showed that 1 per 1000 cerebel